Published Date: 16 Feb 2023
Although there are concerns that the use of Paxlovid increases the risk of COVID-19 returning, the results are clear.
Read Full NewsResidual Asthma Exacerbations on Biologics Vary by Mechanism
Newly announced Phase 4 THRIVE trial results showed most patients who previously had an inadequate response to a CGRP-targeting therapy improved with eptinezumab over 24 weeks.
Catch up on any of the neurology headlines you may have missed in September 2026, compiled into 1 place by the NeurologyLive® team.
Elizabeth Spencer, MD, discusses new data from 3 birth cohorts linking PFAS metabolites tied to maternal IBD to elevated calprotectin in children.
Jordan Axelrad, MD, MPH, discusses first-line IBD therapy selection, sequencing after failure, treat-to-target monitoring, and evaluating new agents
A gastroenterologist explains why IBD symptoms don't always signal a flare, the biomarkers used to confirm inflammation, and counseling patients through Crohn's disease.
ACG Guideline Sets 18 Preventive Care Recommendations for Cirrhosis
1.
Simpler Screening Criteria Could Catch More Lung Cancers
2.
BRAF Inhibition in Pediatric Ameloblastoma of the Jaw
3.
Living near St. Louis-area Coldwater Creek during childhood linked with higher risk of cancer from radiation
4.
Weight loss trial reports success for breast cancer patients at one year mark
5.
Clinical trial could lead to new 'gold standard' test for prostate cancer detection
1.
Exploring the Potential of Xospata: A New Frontier in Cancer Treatment
2.
Demystifying Lymphocytes: Everything You Need to Know
3.
Digital Specimen Tracking for Precision Oncology Workflows
4.
Bone Marrow Immune Niche Remodeling in Hematopoiesis
5.
Late Effects of Immunotherapy in Chronic Melanoma Survivorship with Repurposed Drugs
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation